Article
Infant RSV immunoprophylaxis changes nasal epithelial DNA methylation at 6 years of age
2 Sept 2021
Abstract excerpt
BACKGROUND: Respiratory syncytial virus (RSV) infection has been associated with childhood wheeze and asthma, and potential mechanisms include persistent epigenetic effects. METHODS: In the randomized, placebo-controlled MAKI trial, 429 preterm infants randomly received RSV immunoprophylaxis with palivizumab or placebo during their first RSV season. Children were followed until age 6 for asthma evaluation. DNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
